gepirone
Selected indexed studies
- Gepirone. (, 2006) [PMID:37856644]
- Gepirone Extended-Release: First Approval. (Drugs, 2023) [PMID:38079093]
- Gepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties. (Drugs Today (Barc), 2019) [PMID:31347611]
_Worker-drafted node — pending editorial review._
Connections
gepirone is a side effect of
Sources
- The Black Book of Psychotropic Dosing and Monitoring. (2024) pubmed
- Gepirone. (2006) pubmed
- Gepirone Extended-Release: First Approval. (2023) pubmed
- Gepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties. (2019) pubmed
- Gepirone: A New Extended-Release Oral Selective Serotonin Receptor Agonist for Major Depressive Disorder. (2024) pubmed
- Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review. (2025) pubmed
- Gepirone. Organon. (2001) pubmed
- Gepirone (Exxua) for depression. (2024) pubmed
- A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone. (2003) pubmed
- Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill? (2024) pubmed